Hospice Of Missoula Llc Medicare Approved Location: 800 Kensington Ave Ste 204, Missoula, Montana 59801 Phone: (406) 543-4408 |
Rocky Mountain Hospice Medicare Approved Location: 2409 Dearborn Ave Ste E, Missoula, Montana 59801 Phone: (406) 549-2766 |
Home Health And Hospice Of Montana Medicare Approved Location: 3301 Great Northern Ave 203, Missoula, Montana 59808 Phone: (406) 541-1700 |
Clark Fork Valley Hospital Hospice Medicare Approved Location: 10 Kruger Rd, Plains, Montana 59859 Phone: (406) 826-4863 |
Sheridan Memorial Hospice Medicare Approved Location: 330 W Laurel Ave, Plentywood, Montana 59254 Phone: (406) 765-3733 |
Beartooth Billings Clinic Hospice Medicare Approved Location: 2525 N Broadway, Red Lodge, Montana 59068 Phone: (406) 446-0050 |
Lake County Home Options Medicare Approved Location: 711 Main St Sw, Ronan, Montana 59864 Phone: (406) 751-4200 |
Sidney Health Center Hospice Medicare Approved Location: 216 14th Ave Sw, Sidney, Montana 59270 Phone: (406) 488-2226 |
News Archive
Cook Medical recently launched the endogo HD Portable Endoscopic Imaging System by Envisionier Medical Technology, Inc. The endogo HD has the ability to capture, store and share endoscopic images, making it possible for doctors to share information with patients instantly, simplify collaboration between colleagues and potentially reduce costs by eliminating the need for repeat procedures.
Inhibitex, Inc., announced today that Pfizer Inc. presented safety and immunogenicity data from a Phase 1 double-blind randomized placebo controlled study in 408 healthy volunteers of a novel three antigen Staphylococcus aureus investigational vaccine at the 21st European Congress of Clinical Microbiology and Infectious Diseases and 27th International Congress of Chemotherapy in Milan, Italy.
Eclipsys Corp.® and Microsoft Corp. today announced they have signed an alliance agreement to deliver the choice and flexibility that hospitals need and want to improve health information technology (HIT) efficiencies. Breaking with the tradition of closed, proprietary systems, the two companies will offer the market tightly integrated health IT solutions designed to make it easy for physicians, nurses and hospital administrators to gain insights from data aggregated from multiple clinical and financial systems across the hospital.
Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.
Earlier detection of cardiovascular disease is a step closer thanks to the findings of a research team at the Centro Nacional de Investigaciones Cardiovasculares led by Francisco Sánchez-Madrid and Pilar Martín.
› Verified 3 days ago